MYC on the Path to Cancer

Slides:



Advertisements
Similar presentations
MYC From: Wikipedia Nicholas Britt (Wikipedia, 2008)
Advertisements

MYC, Metabolism and Cancer
Volume 14, Issue 2, Pages (August 2011)
Connecting COX-2 and Wnt in cancer
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
EMT: Matter of Life or Death?
Warren S. Pear, M. Celeste Simon  Cancer Cell 
Stopping the Clock with MYC
New Hope for a MicroRNA Therapy for Liver Cancer
Regulation of Gene Expression
PK-M2 Makes Cells Sweeter on HIF1
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Polycomb Regulates NF-κB Signaling in Cancer through miRNA
Regulating Cancer Stem Cells the miR Way
SIRT6 Puts Cancer Metabolism in the Driver’s Seat
Volume 13, Issue 1, Pages 1-2 (January 2008)
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
Wnt/β-Catenin Signaling: Turning the Switch
Gad Asher, Paolo Sassone-Corsi  Cell 
The Autistic Neuron: Troubled Translation?
Coming up for air: HIF-1 and mitochondrial oxygen consumption
BMP Signaling Goes Posttranscriptional in a microRNA Sort of Way
A, diagram depicting receptor signaling and nutrient import.
In Vino Veritas: A Tale of Two Sirt1s?
Transcriptional Addiction in Cancer
Janus Kinase Deregulation in Leukemia and Lymphoma
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Melanoma: New Insights and New Therapies
Eukaryotic Transcription Activation: Right on Target
FGFR Signaling as a Target for Lung Cancer Therapy
Axis Formation— β-Catenin Catches a Wnt
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Regulation of Primary Response Genes
Nat. Rev. Nephrol. doi: /nrneph
John D. Hayes, Albena T. Dinkova-Kostova  Molecular Cell 
Control of the Embryonic Stem Cell State
Silencing Insulin Resistance through SIRT1
MicroRNA Control in the Immune System: Basic Principles
Into Thin Air: How We Sense and Respond to Hypoxia
AKT/PKB Signaling: Navigating the Network
NOTCH and PI3K-AKT Pathways Intertwined
Proteins Kinases: Chromatin-Associated Enzymes?
AKT/PKB Signaling: Navigating Downstream
Easy Stress Relief by EZH2
p38δ and PKD1: Kinase Switches for Insulin Secretion
SRC and STAT Pathways Journal of Thoracic Oncology
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Advances in Hypoxia-Inducible Factor Biology
John D. Hayes, Albena T. Dinkova-Kostova  Molecular Cell 
Ekaterina Pak, Rosalind A. Segal  Developmental Cell 
Wnt/β-Catenin Signaling in Development and Disease
Modes of p53 Regulation Cell
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Genes frequently mutated in colorectal cancer and their relationships with miRNAs. Genes frequently mutated in colorectal cancer and their relationships.
Volume 14, Issue 2, Pages (August 2011)
Slugging It out: Fine Tuning the p53-PUMA Death Connection
Pok Kwan Yang, Mitzi I. Kuroda  Cell 
Shared Principles in NF-κB Signaling
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
PK-M2 Makes Cells Sweeter on HIF1
Volume 119, Issue 4, Pages (October 2000)
Selective Transcription in Response to an Inflammatory Stimulus
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
Taking LSD1 to a New High Cell
YAP1 Takes Over when Oncogenic K-Ras Slumbers
Tenets of PTEN Tumor Suppression
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Long Noncoding RNAs in Cancer Pathways
No Driver behind the Wheel? Targeting Transcription in Cancer
Presentation transcript:

MYC on the Path to Cancer Chi V. Dang  Cell  Volume 149, Issue 1, Pages 22-35 (March 2012) DOI: 10.1016/j.cell.2012.03.003 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Myc Regulates Cell Growth and Proliferation (A) The MYC protooncogene is depicted downstream of receptor signal transduction pathways, which elicit positive or negative regulation of the MYC gene. MYC produces the transcription factor Myc, which dimerizes with Max and binds target DNA sequences or E boxes (with the sequence 5′-CANNTG-3′) to regulate transcription of genes involved in cell growth and proliferation. The WNT pathway is depicted with APC negatively regulating β-catenin, which upon nuclear translocation participates in the transactivation of MYC, such that loss of APC results in constitutive oncogenic MYC expression. (B) When MYC is deregulated, by gene amplication, chromosomal translocation, or loss of upstream regulators, such as APC, acute sustained oncogenic MYC expression results in checkpoint activation of p53 or Arf. Loss of checkpoint regulation through mutations of p53 or Arf, for example, uncloaks MYC's full tumorigenic potential. Cell 2012 149, 22-35DOI: (10.1016/j.cell.2012.03.003) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Myc-Max-Mediated Transcription and Gene Repression (A) The Myc-Max heterodimer is shown to interact with key cofactors, such as transcription factor 2H (TFIIH) that triggers transcriptional elongation or transformation/transcription domain-associated protein (TRRAP) that recruits the GCN5, which acetylates histones, permitting transcription of target genes. (B) Myc-Max also mediates gene repression. Miz-1 is shown tethered to the initiator (INR) element to regulate transcription of target genes, which could be silenced by Myc displacement of nucleophosmin (NPM), a Miz-1 cofactor, or Myc induction of the ribosomal protein RPL23, which retains NPM in the nucleolus, keeping it away from Miz-1. Cell 2012 149, 22-35DOI: (10.1016/j.cell.2012.03.003) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 The Myc miRNA Network Myc regulates a network of miRNAs through activation of the miR-17-92 cluster and repression of dozens of miRs including Let-7, which was recently shown to affect insulin signaling, miR-23a/b, which regulates glutaminase expression, and miR-34a, which was shown to regulate lactate dehydrogenase (LDHA) expression. The miR-17 cluster contains miRNAs that target PTEN, thereby activating AKT, and those that target proapoptotic BimL or transcription factor E2F1 expression. miRNAs downstream of Myc have also been implicated in EMT and angiogenesis. Cell 2012 149, 22-35DOI: (10.1016/j.cell.2012.03.003) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 Homeostatic and Proliferative Regulation of E Box-Driven Genes Myc-Max is shown bound to E box-driven genes, which could also be regulated by other E box transcription factors, such as the carbohydrate response element-binding protein (ChREBP), sterol response element-binding protein (SREBP), nuclear respiratory factor 1 (NRF1), circadian transcription factor Clock (and Bmal), and hypoxia-inducible factor (HIF). The non-Myc E box transcription factors regulate genes involved in metabolism, which is maintained for cellular homeostasis when cells are not proliferating. Upon activation of MYC and elevated levels of Myc, mass action favors the binding of Myc-Max to E box genes to regulate metabolism and genes involved in ribosomal biogenesis and cell mass accumulation. This model suggests that resting cells express metabolic genes through “homeostatic” E box transcription factors, which regulate a set of genes that overlaps with Myc target genes that are expressed when cells are stimulated to grow and proliferate. Cell 2012 149, 22-35DOI: (10.1016/j.cell.2012.03.003) Copyright © 2012 Elsevier Inc. Terms and Conditions